Fulcrum Therapeutics FULC narrows Q1 loss 18 more than expected despite zero revenue shares rise 2 The supply chain story behind Propanc Biopharma PPCB earnings FFIN First Financial Bankshares Inc tops Q1 2026 consensus EPS estimates shares climb 488 percent on upbeat investor sentiment LNZA LanzaTech Global falls 747 percent post Q4 2025 earnings despite sharp EPS beat over analyst estimates Data IO DAIO Stock Support and Resistance Zones Runs Up 20260427 Why investors are rethinking Laser LASE Rallies Strongly 20260506 US Productivity Growth Eases in Q4 as Labor Costs Accelerate EMN Q1 2026 Earnings EPS Beats Estimates by 17 as Stock Edges Up Japan and Philippines Deepen Strategic Ties Amid Regional Security Concerns